[1]
Żuber, M. et al. 2024. The role of nintedanib and pirfenidone in the treatment of idiopathic pulmonary fibrosis and review of recent clinical trials of IPF therapy. Quality in Sport. 20, (Jun. 2024), 51395. DOI:https://doi.org/10.12775/QS.2024.20.51395.